APO Research
Talk to an analyst

APO RESEARCH · REPORT

Naloxone

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Naloxone Industry Growth and Trends Forecast to 2032

20 December 202596 pages

Choose your research edition.

Industry ResearchNaloxone Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Naloxone Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Naloxone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Naloxone Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Naloxone Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Naloxone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Naloxone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Naloxone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Naloxone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Naloxone include ADAPT Pharma, Amneal Pharmaceuticals, Amphastar Pharmaceuticals, Kaleo, West Ward Pharmaceuticals, Pfizer, Mylan and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Naloxone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Naloxone market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Naloxone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Naloxone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Naloxone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Naloxone Market by Company

ADAPT Pharma

Amneal Pharmaceuticals

Amphastar Pharmaceuticals

Kaleo

West Ward Pharmaceuticals

Pfizer

Mylan

Sandoz

Naloxone Segment by Type

Spray Forms

Injectable Forms

Naloxone Segment by Application

Hospital Pharmacies

Drug Store

Online

Naloxone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Naloxone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Naloxone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Naloxone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Naloxone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Naloxone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Spray Forms Table 2. Major Company of Injectable Forms Table 3. Global Naloxone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Naloxone Sales by Type (2021-2026) & (W Units) Table 5. Global Naloxone Sales Market Share in Volume by Type (2021-2026) Table 6. Global Naloxone Sales by Type (2021-2026) & (US$ Million) Table 7. Global Naloxone Sales Market Share in Value by Type (2021-2026) Table 8. Global Naloxone Price by Type (2021-2026) & (US$/Unit) Table 9. Global Naloxone Sales by Type (2027-2032) & (W Units) Table 10. Global Naloxone Sales Market Share in Volume by Type (2027-2032) Table 11. Global Naloxone Sales by Type (2027-2032) & (US$ Million) Table 12. Global Naloxone Sales Market Share in Value by Type (2027-2032) Table 13. Global Naloxone Price by Type (2027-2032) & (US$/Unit) Table 14. North America Naloxone Sales by Type (2021-2026) & (W Units) Table 15. North America Naloxone Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Naloxone Sales by Type (2021-2026) & (W Units) Table 17. Europe Naloxone Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Naloxone Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Naloxone Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Naloxone Sales by Type (2021-2026) & (W Units) Table 21. Latin America Naloxone Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Naloxone Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Naloxone Sales by Type (2021-2026) & (US$ Million) Table 24. Naloxone Industry Trends Table 25. Naloxone Industry Drivers Table 26. Naloxone Industry Opportunities and Challenges Table 27. Naloxone Industry Restraints Table 28. Global Naloxone Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Naloxone Revenue Market Share by Company (2021-2026) Table 30. Global Naloxone Sales by Company (2021-2026) & (W Units) Table 31. Global Naloxone Sales Share by Company (2021-2026) Table 32. Global Naloxone Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Naloxone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Naloxone Major Company Production Sites and Headquarters Table 35. Global Naloxone Company, Product Type & Application Table 36. Global Naloxone Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Naloxone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Naloxone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Naloxone Sales by Region (2021-2026) & (W Units) Table 41. Global Naloxone Sales Market Share in Volume by Region (2021-2026) Table 42. Global Naloxone Sales by Region (2021-2026) & (US$ Million) Table 43. Global Naloxone Sales Market Share in Value by Region (2021-2026) Table 44. Global Naloxone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Naloxone Sales by Region (2027-2032) & (W Units) Table 46. Global Naloxone Sales Market Share in Volume by Region (2027-2032) Table 47. Global Naloxone Sales by Region (2027-2032) & (US$ Million) Table 48. Global Naloxone Sales Market Share in Value by Region (2027-2032) Table 49. Global Naloxone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Naloxone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Naloxone Sales by Application (2021-2026) & (W Units) Table 52. Global Naloxone Sales Market Share in Volume by Application (2021-2026) Table 53. Global Naloxone Sales by Application (2021-2026) & (US$ Million) Table 54. Global Naloxone Sales Market Share in Value by Application (2021-2026) Table 55. Global Naloxone Price by Application (2021-2026) & (US$/Unit) Table 56. Global Naloxone Sales by Application (2027-2032) & (W Units) Table 57. Global Naloxone Sales Market Share in Volume by Application (2027-2032) Table 58. Global Naloxone Sales by Application (2027-2032) & (US$ Million) Table 59. Global Naloxone Sales Market Share in Value by Application (2027-2032) Table 60. Global Naloxone Price by Application (2027-2032) & (US$/Unit) Table 61. North America Naloxone Sales by Application (2021-2026) & (W Units) Table 62. North America Naloxone Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Naloxone Sales by Application (2021-2026) & (W Units) Table 64. Europe Naloxone Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Naloxone Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Naloxone Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Naloxone Sales by Application (2021-2026) & (W Units) Table 68. Latin America Naloxone Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Naloxone Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Naloxone Sales by Application (2021-2026) & (US$ Million) Table 71. ADAPT Pharma Company Information Table 72. ADAPT Pharma Business Overview Table 73. ADAPT Pharma Naloxone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. ADAPT Pharma Naloxone Product Portfolio Table 75. ADAPT Pharma Recent Development Table 76. Amneal Pharmaceuticals Company Information Table 77. Amneal Pharmaceuticals Business Overview Table 78. Amneal Pharmaceuticals Naloxone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Amneal Pharmaceuticals Naloxone Product Portfolio Table 80. Amneal Pharmaceuticals Recent Development Table 81. Amphastar Pharmaceuticals Company Information Table 82. Amphastar Pharmaceuticals Business Overview Table 83. Amphastar Pharmaceuticals Naloxone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Amphastar Pharmaceuticals Naloxone Product Portfolio Table 85. Amphastar Pharmaceuticals Recent Development Table 86. Kaleo Company Information Table 87. Kaleo Business Overview Table 88. Kaleo Naloxone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Kaleo Naloxone Product Portfolio Table 90. Kaleo Recent Development Table 91. West Ward Pharmaceuticals Company Information Table 92. West Ward Pharmaceuticals Business Overview Table 93. West Ward Pharmaceuticals Naloxone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. West Ward Pharmaceuticals Naloxone Product Portfolio Table 95. West Ward Pharmaceuticals Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Naloxone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Pfizer Naloxone Product Portfolio Table 100. Pfizer Recent Development Table 101. Mylan Company Information Table 102. Mylan Business Overview Table 103. Mylan Naloxone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Mylan Naloxone Product Portfolio Table 105. Mylan Recent Development Table 106. Sandoz Company Information Table 107. Sandoz Business Overview Table 108. Sandoz Naloxone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Sandoz Naloxone Product Portfolio Table 110. Sandoz Recent Development Table 111. North America Naloxone Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 112. North America Naloxone Sales by Country (2021-2026) & (W Units) Table 113. North America Naloxone Sales Market Share by Country (2021-2026) Table 114. North America Naloxone Sales Forecast by Country (2027-2032) & (W Units) Table 115. North America Naloxone Sales Market Share Forecast by Country (2027-2032) Table 116. North America Naloxone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Naloxone Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Naloxone Market Share by Country (2021-2026) Table 119. North America Naloxone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Naloxone Market Share Forecast by Country (2027-2032) Table 121. Europe Naloxone Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 122. Europe Naloxone Sales by Country (2021-2026) & (W Units) Table 123. Europe Naloxone Sales Market Share by Country (2021-2026) Table 124. Europe Naloxone Sales Forecast by Country (2027-2032) & (W Units) Table 125. Europe Naloxone Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Naloxone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Naloxone Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Naloxone Market Share by Country (2021-2026) Table 129. Europe Naloxone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Naloxone Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Naloxone Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Naloxone Sales by Country (2021-2026) & (W Units) Table 133. Asia-Pacific Naloxone Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Naloxone Sales Forecast by Country (2027-2032) & (W Units) Table 135. Asia-Pacific Naloxone Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Naloxone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Naloxone Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Naloxone Market Share by Country (2021-2026) Table 139. Asia-Pacific Naloxone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Naloxone Market Share Forecast by Country (2027-2032) Table 141. Latin America Naloxone Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 142. Latin America Naloxone Sales by Country (2021-2026) & (W Units) Table 143. Latin America Naloxone Sales Market Share by Country (2021-2026) Table 144. Latin America Naloxone Sales Forecast by Country (2027-2032) & (W Units) Table 145. Latin America Naloxone Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Naloxone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Naloxone Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Naloxone Market Share by Country (2021-2026) Table 149. Latin America Naloxone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Naloxone Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Naloxone Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Naloxone Sales by Country (2021-2026) & (W Units) Table 153. Middle East and Africa Naloxone Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Naloxone Sales Forecast by Country (2027-2032) & (W Units) Table 155. Middle East and Africa Naloxone Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Naloxone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Naloxone Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Naloxone Market Share by Country (2021-2026) Table 159. Middle East and Africa Naloxone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Naloxone Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Naloxone Distributors List Table 164. Naloxone Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Naloxone Image Figure 2. Global Naloxone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Naloxone Market Size (2021-2032) & (US$ Million) Figure 4. Global Naloxone Sales (2021-2032) & (W Units) Figure 5. Spray Forms Image Figure 6. Global Spray Forms Sales YoY Growth (2021-2032) & (W Units) Figure 7. Injectable Forms Image Figure 8. Global Injectable Forms Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Naloxone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Naloxone Market Share by Type 2025 VS 2032 Figure 11. North America Naloxone Sales Market Share in Volume by Type in 2025 Figure 12. North America Naloxone Sales Market Share in Value by Type in 2025 Figure 13. Europe Naloxone Sales Market Share in Volume by Type in 2025 Figure 14. Europe Naloxone Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Naloxone Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Naloxone Sales Market Share in Value by Type in 2025 Figure 17. Latin America Naloxone Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Naloxone Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Naloxone Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Naloxone Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Naloxone Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Pharmacies Image Figure 24. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (W Units) Figure 25. Drug Store Image Figure 26. Global Drug Store Sales YoY Growth (2021-2032) & (W Units) Figure 27. Online Image Figure 28. Global Online Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Naloxone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Naloxone Market Share by Application 2025 VS 2032 Figure 31. North America Naloxone Sales Market Share in Volume by Application in 2025 Figure 32. North America Naloxone Sales Market Share in Value by Application in 2025 Figure 33. Europe Naloxone Sales Market Share in Volume by Application in 2025 Figure 34. Europe Naloxone Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Naloxone Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Naloxone Sales Market Share in Value by Application in 2025 Figure 37. Latin America Naloxone Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Naloxone Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Naloxone Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Naloxone Sales Market Share in Value by Application in 2025 Figure 41. North America Naloxone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Naloxone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Naloxone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Naloxone Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Naloxone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Naloxone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Naloxone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Naloxone Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Naloxone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Naloxone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Naloxone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Naloxone Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Naloxone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Naloxone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Naloxone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Naloxone Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Naloxone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Naloxone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Naloxone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Naloxone Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Naloxone Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Naloxone Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Spray Forms
  • Injectable Forms
Applications
  • Hospital Pharmacies
  • Drug Store
  • Online
Companies covered
  • ADAPT Pharma
  • Amneal Pharmaceuticals
  • Amphastar Pharmaceuticals
  • Kaleo
  • West Ward Pharmaceuticals
  • Pfizer
  • Mylan
  • Sandoz

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Naloxone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Naloxone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Naloxone Market by Type
  6. 1.3.1 Spray Forms
  7. 1.3.2 Injectable Forms
  8. 1.4 Global Naloxone Market Size by Type
  9. 1.4.1 Global Naloxone Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Naloxone Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Naloxone Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Naloxone Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Naloxone Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Naloxone Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Naloxone Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Naloxone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Naloxone Industry Trends
  2. 2.2 Naloxone Industry Drivers
  3. 2.3 Naloxone Industry Opportunities and Challenges
  4. 2.4 Naloxone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Naloxone Revenue (2021-2026)
  2. 3.2 Global Top Players by Naloxone Sales (2021-2026)
  3. 3.3 Global Top Players by Naloxone Price (2021-2026)
  4. 3.4 Global Naloxone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Naloxone Major Company Production Sites & Headquarters
  6. 3.6 Global Naloxone Company, Product Type & Application
  7. 3.7 Global Naloxone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Naloxone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Naloxone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Naloxone Tier 1, Tier 2, and Tier 3
4 Naloxone Regional Status and Outlook
  1. 4.1 Global Naloxone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Naloxone Historic Market Size by Region
  3. 4.2.1 Global Naloxone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Naloxone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Naloxone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Naloxone Forecasted Market Size by Region
  7. 4.3.1 Global Naloxone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Naloxone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Naloxone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Naloxone by Application
  1. 5.1 Naloxone Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Store
  4. 5.1.3 Online
  5. 5.2 Global Naloxone Market Size by Application
  6. 5.2.1 Global Naloxone Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Naloxone Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Naloxone Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Naloxone Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Naloxone Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Naloxone Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Naloxone Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Naloxone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ADAPT Pharma
  2. 6.1.1 ADAPT Pharma Company Information
  3. 6.1.2 ADAPT Pharma Business Overview
  4. 6.1.3 ADAPT Pharma Naloxone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ADAPT Pharma Naloxone Product Portfolio
  6. 6.1.5 ADAPT Pharma Recent Developments
  7. 6.2 Amneal Pharmaceuticals
  8. 6.2.1 Amneal Pharmaceuticals Company Information
  9. 6.2.2 Amneal Pharmaceuticals Business Overview
  10. 6.2.3 Amneal Pharmaceuticals Naloxone Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Amneal Pharmaceuticals Naloxone Product Portfolio
  12. 6.2.5 Amneal Pharmaceuticals Recent Developments
  13. 6.3 Amphastar Pharmaceuticals
  14. 6.3.1 Amphastar Pharmaceuticals Company Information
  15. 6.3.2 Amphastar Pharmaceuticals Business Overview
  16. 6.3.3 Amphastar Pharmaceuticals Naloxone Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amphastar Pharmaceuticals Naloxone Product Portfolio
  18. 6.3.5 Amphastar Pharmaceuticals Recent Developments
  19. 6.4 Kaleo
  20. 6.4.1 Kaleo Company Information
  21. 6.4.2 Kaleo Business Overview
  22. 6.4.3 Kaleo Naloxone Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kaleo Naloxone Product Portfolio
  24. 6.4.5 Kaleo Recent Developments
  25. 6.5 West Ward Pharmaceuticals
  26. 6.5.1 West Ward Pharmaceuticals Company Information
  27. 6.5.2 West Ward Pharmaceuticals Business Overview
  28. 6.5.3 West Ward Pharmaceuticals Naloxone Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 West Ward Pharmaceuticals Naloxone Product Portfolio
  30. 6.5.5 West Ward Pharmaceuticals Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Naloxone Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Naloxone Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Mylan
  38. 6.7.1 Mylan Company Information
  39. 6.7.2 Mylan Business Overview
  40. 6.7.3 Mylan Naloxone Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mylan Naloxone Product Portfolio
  42. 6.7.5 Mylan Recent Developments
  43. 6.8 Sandoz
  44. 6.8.1 Sandoz Company Information
  45. 6.8.2 Sandoz Business Overview
  46. 6.8.3 Sandoz Naloxone Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sandoz Naloxone Product Portfolio
  48. 6.8.5 Sandoz Recent Developments
7 North America by Country
  1. 7.1 North America Naloxone Sales by Country
  2. 7.1.1 North America Naloxone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Naloxone Sales by Country (2021-2026)
  4. 7.1.3 North America Naloxone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Naloxone Market Size by Country
  6. 7.2.1 North America Naloxone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Naloxone Market Size by Country (2021-2026)
  8. 7.2.3 North America Naloxone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Naloxone Sales by Country
  2. 8.1.1 Europe Naloxone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Naloxone Sales by Country (2021-2026)
  4. 8.1.3 Europe Naloxone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Naloxone Market Size by Country
  6. 8.2.1 Europe Naloxone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Naloxone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Naloxone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Naloxone Sales by Country
  2. 9.1.1 Asia-Pacific Naloxone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Naloxone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Naloxone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Naloxone Market Size by Country
  6. 9.2.1 Asia-Pacific Naloxone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Naloxone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Naloxone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Naloxone Sales by Country
  2. 10.1.1 South America Naloxone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Naloxone Sales by Country (2021-2026)
  4. 10.1.3 South America Naloxone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Naloxone Market Size by Country
  6. 10.2.1 South America Naloxone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Naloxone Market Size by Country (2021-2026)
  8. 10.2.3 South America Naloxone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Naloxone Sales by Country
  2. 11.1.1 Middle East and Africa Naloxone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Naloxone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Naloxone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Naloxone Market Size by Country
  6. 11.2.1 Middle East and Africa Naloxone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Naloxone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Naloxone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Naloxone Value Chain Analysis
  2. 12.1.1 Naloxone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Naloxone Production Mode & Process
  7. 12.2 Naloxone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Naloxone Distributors
  10. 12.2.3 Naloxone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst